INVO Fertility authorized shares increased to 50M from 1.39M; issues $200k preferred

INVO Fertility, Inc.

Shareholders approved increasing authorized common shares from 1,388,888 to 50,000,000; vote: 643,612 for, 219,764 against, 5,008 abstain.
Issued 200 shares of Series C-2 Convertible Preferred Stock for $200,000 cash to an institutional investor/existing holder.
Conversion price on C-2 Preferred adjusted to $0.6651 pre-split; post 1-for-3 reverse split effective July 21, 2025, conversion price is $1.9953.
Securities issued under Section 4(a)(2)/Rule 506 exemption without registration.

item 3.02item 1.01item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.